Stifel Trust’s Allergan plc AGN Stock Holding History

Stifel Trust’s Portfolio AGN Stock Details AGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2013 Q4	–	Sell	-50	Closed	-$8K	–	453
2013 Q3	$8K	Hold	50	–	–	﹤0.01%	405
2013 Q2	$7K	Buy	+50	New	+$5.66K	﹤0.01%	408

Other funds holding AGN

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return

Sculptor Capital New York $9.61B AUM 27.49% 1-Year Est. Return

OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Stifel Trust's AGN Position: Q4 2013 in Review

Stifel Trust sold out of Allergan plc (AGN) in Q4 2013, closing a stake of 50 shares — an estimated $8K sold.

Stifel Trust first reported a position in AGN in Q2 2013 and held it in 2 quarters. The position peaked at $8K in Q3 2013. 552 funds tracked by Wall St. Rank hold AGN as of Q4 2013.

Stifel Trust reported no remaining Allergan plc position as of Q4 2013 after selling out during the quarter.
Stifel Trust sold 50 Allergan plc shares in Q4 2013, an estimated $8K.
Stifel Trust first reported a position in Allergan plc in Q2 2013 and held it in 2 quarters.
Stifel Trust's Allergan plc position peaked at $8K in Q3 2013.
552 funds tracked by Wall St. Rank held Allergan plc as of Q4 2013.

Based on Stifel Trust's 13F filing for Q4 2013, filed 14 Feb 2014.